カテゴリ： 世界, 医療/バイオ, QYResearch

がん治療薬の世界市場2023年：化学療法薬品、分子標的治療薬品、免疫療法薬品、ホルモン療法薬品、その他

■ 英語タイトル：Global Treat Oncology Drug Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8911）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8911
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[がん治療薬の世界市場2023年：化学療法薬品、分子標的治療薬品、免疫療法薬品、ホルモン療法薬品、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はがん治療薬のグローバル市場について調査・分析し、世界のがん治療薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（化学療法薬品、分子標的治療薬品、免疫療法薬品、ホルモン療法薬品、その他）、用途別セグメント分析（血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Novartis AG、CELGENE CORPORATION、Merck & Company Inc、Pfizer Inc.、Johnson & Johnson、Roche、GlaxoSmithKline plc、AstraZeneca、Teva Pharmaceutical Industries Ltd、Takeda、Astellas、NATCO Pharma Limited、Amgen、Ipsen、Aurobindo Pharma、Hikma Pharmaceuticals PLC、Mylan、Sanofi、Bayer、Biogen Idecなどが含まれています。がん治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、がん治療薬市場規模を算出する際に考慮しました。

・がん治療薬市場の概要
- 製品の定義
- がん治療薬の種類別セグメント
- 世界のがん治療薬市場規模：タイプ別分析（化学療法薬品、分子標的治療薬品、免疫療法薬品、ホルモン療法薬品、その他）
- がん治療薬の用途別セグメント
- 世界のがん治療薬市場規模：用途別分析（血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他）
- 世界のがん治療薬市場規模予測（2018年-2029年）
- がん治療薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- がん治療薬市場の競争状況およびトレンド

・がん治療薬の地域別市場規模
- 北米のがん治療薬市場規模（2018年-2029年）
- 米国のがん治療薬市場規模（2018年-2029年）
- ヨーロッパのがん治療薬市場規模（2018年-2029年）
- アジア太平洋のがん治療薬市場規模（2018年-2029年）
- 中国のがん治療薬市場規模（2018年-2029年）
- 日本のがん治療薬市場規模（2018年-2029年）
- 韓国のがん治療薬市場規模（2018年-2029年）
- インドのがん治療薬市場規模（2018年-2029年）
- オーストラリアのがん治療薬市場規模（2018年-2029年）
- 中南米のがん治療薬市場規模（2018年-2029年）
- 中東・アフリカのがん治療薬市場規模（2018年-2029年）

・種類別セグメント：化学療法薬品、分子標的治療薬品、免疫療法薬品、ホルモン療法薬品、その他
- 世界のがん治療薬のタイプ別販売量（2018年-2023年）
- 世界のがん治療薬のタイプ別売上（2018年-2023年）
- 世界のがん治療薬のタイプ別価格

・用途別セグメント：血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他
- 世界のがん治療薬の用途別販売量（2018年-2023年）
- 世界のがん治療薬の用途別売上（2018年-2023年）
- 世界のがん治療薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Novartis AG、CELGENE CORPORATION、Merck & Company Inc、Pfizer Inc.、Johnson & Johnson、Roche、GlaxoSmithKline plc、AstraZeneca、Teva Pharmaceutical Industries Ltd、Takeda、Astellas、NATCO Pharma Limited、Amgen、Ipsen、Aurobindo Pharma、Hikma Pharmaceuticals PLC、Mylan、Sanofi、Bayer、Biogen Idec

・産業チェーンと販売チャネルの分析
- がん治療薬産業チェーン分析
- がん治療薬の主要原材料
- がん治療薬の販売チャネル
- がん治療薬のディストリビューター
- がん治療薬の主要顧客

・がん治療薬市場ダイナミクス
- がん治療薬の業界動向
- がん治療薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Treat Oncology Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Treat Oncology Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Treat Oncology Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Treat Oncology Drug include Novartis AG, CELGENE CORPORATION, Merck & Company Inc, Pfizer Inc., Johnson & Johnson, Roche, GlaxoSmithKline plc, AstraZeneca and Teva Pharmaceutical Industries Ltd, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Treat Oncology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treat Oncology Drug.
The Treat Oncology Drug market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Treat Oncology Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Treat Oncology Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Novartis AG
CELGENE CORPORATION
Merck & Company Inc
Pfizer Inc.
Johnson & Johnson
Roche
GlaxoSmithKline plc
AstraZeneca
Teva Pharmaceutical Industries Ltd
Takeda
Astellas
NATCO Pharma Limited
Amgen
Ipsen
Aurobindo Pharma
Hikma Pharmaceuticals PLC
Mylan
Sanofi
Bayer
Biogen Idec
Segment by Type
Chemotherapy Drug
Targeted Therapy Drug
Immunotherapy Drug
Hormone Therapy Drug
Others
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Treat Oncology Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Treat Oncology Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Treat Oncology Drug Market Overview
1.1 Product Overview and Scope of Treat Oncology Drug
1.2 Treat Oncology Drug Segment by Type
1.2.1 Global Treat Oncology Drug Market Value Comparison by Type (2023-2029)
1.2.2 Chemotherapy Drug
1.2.3 Targeted Therapy Drug
1.2.4 Immunotherapy Drug
1.2.5 Hormone Therapy Drug
1.2.6 Others
1.3 Treat Oncology Drug Segment by Application
1.3.1 Global Treat Oncology Drug Market Value by Application: (2023-2029)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Others
1.4 Global Treat Oncology Drug Market Size Estimates and Forecasts
1.4.1 Global Treat Oncology Drug Revenue 2018-2029
1.4.2 Global Treat Oncology Drug Sales 2018-2029
1.4.3 Global Treat Oncology Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Treat Oncology Drug Market Competition by Manufacturers
2.1 Global Treat Oncology Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Treat Oncology Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Treat Oncology Drug Average Price by Manufacturers (2018-2023)
2.4 Global Treat Oncology Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Treat Oncology Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Treat Oncology Drug, Product Type & Application
2.7 Treat Oncology Drug Market Competitive Situation and Trends
2.7.1 Treat Oncology Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Treat Oncology Drug Players Market Share by Revenue
2.7.3 Global Treat Oncology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Treat Oncology Drug Retrospective Market Scenario by Region
3.1 Global Treat Oncology Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Treat Oncology Drug Global Treat Oncology Drug Sales by Region: 2018-2029
3.2.1 Global Treat Oncology Drug Sales by Region: 2018-2023
3.2.2 Global Treat Oncology Drug Sales by Region: 2024-2029
3.3 Global Treat Oncology Drug Global Treat Oncology Drug Revenue by Region: 2018-2029
3.3.1 Global Treat Oncology Drug Revenue by Region: 2018-2023
3.3.2 Global Treat Oncology Drug Revenue by Region: 2024-2029
3.4 North America Treat Oncology Drug Market Facts & Figures by Country
3.4.1 North America Treat Oncology Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Treat Oncology Drug Sales by Country (2018-2029)
3.4.3 North America Treat Oncology Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Treat Oncology Drug Market Facts & Figures by Country
3.5.1 Europe Treat Oncology Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Treat Oncology Drug Sales by Country (2018-2029)
3.5.3 Europe Treat Oncology Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Treat Oncology Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Treat Oncology Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Treat Oncology Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Treat Oncology Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Treat Oncology Drug Market Facts & Figures by Country
3.7.1 Latin America Treat Oncology Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Treat Oncology Drug Sales by Country (2018-2029)
3.7.3 Latin America Treat Oncology Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Treat Oncology Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Treat Oncology Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Treat Oncology Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Treat Oncology Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Treat Oncology Drug Sales by Type (2018-2029)
4.1.1 Global Treat Oncology Drug Sales by Type (2018-2023)
4.1.2 Global Treat Oncology Drug Sales by Type (2024-2029)
4.1.3 Global Treat Oncology Drug Sales Market Share by Type (2018-2029)
4.2 Global Treat Oncology Drug Revenue by Type (2018-2029)
4.2.1 Global Treat Oncology Drug Revenue by Type (2018-2023)
4.2.2 Global Treat Oncology Drug Revenue by Type (2024-2029)
4.2.3 Global Treat Oncology Drug Revenue Market Share by Type (2018-2029)
4.3 Global Treat Oncology Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Treat Oncology Drug Sales by Application (2018-2029)
5.1.1 Global Treat Oncology Drug Sales by Application (2018-2023)
5.1.2 Global Treat Oncology Drug Sales by Application (2024-2029)
5.1.3 Global Treat Oncology Drug Sales Market Share by Application (2018-2029)
5.2 Global Treat Oncology Drug Revenue by Application (2018-2029)
5.2.1 Global Treat Oncology Drug Revenue by Application (2018-2023)
5.2.2 Global Treat Oncology Drug Revenue by Application (2024-2029)
5.2.3 Global Treat Oncology Drug Revenue Market Share by Application (2018-2029)
5.3 Global Treat Oncology Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis AG Treat Oncology Drug Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 CELGENE CORPORATION
6.2.1 CELGENE CORPORATION Corporation Information
6.2.2 CELGENE CORPORATION Description and Business Overview
6.2.3 CELGENE CORPORATION Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CELGENE CORPORATION Treat Oncology Drug Product Portfolio
6.2.5 CELGENE CORPORATION Recent Developments/Updates
6.3 Merck & Company Inc
6.3.1 Merck & Company Inc Corporation Information
6.3.2 Merck & Company Inc Description and Business Overview
6.3.3 Merck & Company Inc Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck & Company Inc Treat Oncology Drug Product Portfolio
6.3.5 Merck & Company Inc Recent Developments/Updates
6.4 Pfizer Inc.
6.4.1 Pfizer Inc. Corporation Information
6.4.2 Pfizer Inc. Description and Business Overview
6.4.3 Pfizer Inc. Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Inc. Treat Oncology Drug Product Portfolio
6.4.5 Pfizer Inc. Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Johnson & Johnson Treat Oncology Drug Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Roche Treat Oncology Drug Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 GlaxoSmithKline plc
6.6.1 GlaxoSmithKline plc Corporation Information
6.6.2 GlaxoSmithKline plc Description and Business Overview
6.6.3 GlaxoSmithKline plc Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline plc Treat Oncology Drug Product Portfolio
6.7.5 GlaxoSmithKline plc Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Treat Oncology Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Teva Pharmaceutical Industries Ltd
6.9.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.9.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.9.3 Teva Pharmaceutical Industries Ltd Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Teva Pharmaceutical Industries Ltd Treat Oncology Drug Product Portfolio
6.9.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Corporation Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Takeda Treat Oncology Drug Product Portfolio
6.10.5 Takeda Recent Developments/Updates
6.11 Astellas
6.11.1 Astellas Corporation Information
6.11.2 Astellas Treat Oncology Drug Description and Business Overview
6.11.3 Astellas Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Astellas Treat Oncology Drug Product Portfolio
6.11.5 Astellas Recent Developments/Updates
6.12 NATCO Pharma Limited
6.12.1 NATCO Pharma Limited Corporation Information
6.12.2 NATCO Pharma Limited Treat Oncology Drug Description and Business Overview
6.12.3 NATCO Pharma Limited Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 NATCO Pharma Limited Treat Oncology Drug Product Portfolio
6.12.5 NATCO Pharma Limited Recent Developments/Updates
6.13 Amgen
6.13.1 Amgen Corporation Information
6.13.2 Amgen Treat Oncology Drug Description and Business Overview
6.13.3 Amgen Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Amgen Treat Oncology Drug Product Portfolio
6.13.5 Amgen Recent Developments/Updates
6.14 Ipsen
6.14.1 Ipsen Corporation Information
6.14.2 Ipsen Treat Oncology Drug Description and Business Overview
6.14.3 Ipsen Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Ipsen Treat Oncology Drug Product Portfolio
6.14.5 Ipsen Recent Developments/Updates
6.15 Aurobindo Pharma
6.15.1 Aurobindo Pharma Corporation Information
6.15.2 Aurobindo Pharma Treat Oncology Drug Description and Business Overview
6.15.3 Aurobindo Pharma Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Aurobindo Pharma Treat Oncology Drug Product Portfolio
6.15.5 Aurobindo Pharma Recent Developments/Updates
6.16 Hikma Pharmaceuticals PLC
6.16.1 Hikma Pharmaceuticals PLC Corporation Information
6.16.2 Hikma Pharmaceuticals PLC Treat Oncology Drug Description and Business Overview
6.16.3 Hikma Pharmaceuticals PLC Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Hikma Pharmaceuticals PLC Treat Oncology Drug Product Portfolio
6.16.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
6.17 Mylan
6.17.1 Mylan Corporation Information
6.17.2 Mylan Treat Oncology Drug Description and Business Overview
6.17.3 Mylan Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Mylan Treat Oncology Drug Product Portfolio
6.17.5 Mylan Recent Developments/Updates
6.18 Sanofi
6.18.1 Sanofi Corporation Information
6.18.2 Sanofi Treat Oncology Drug Description and Business Overview
6.18.3 Sanofi Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Sanofi Treat Oncology Drug Product Portfolio
6.18.5 Sanofi Recent Developments/Updates
6.19 Bayer
6.19.1 Bayer Corporation Information
6.19.2 Bayer Treat Oncology Drug Description and Business Overview
6.19.3 Bayer Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Bayer Treat Oncology Drug Product Portfolio
6.19.5 Bayer Recent Developments/Updates
6.20 Biogen Idec
6.20.1 Biogen Idec Corporation Information
6.20.2 Biogen Idec Treat Oncology Drug Description and Business Overview
6.20.3 Biogen Idec Treat Oncology Drug Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Biogen Idec Treat Oncology Drug Product Portfolio
6.20.5 Biogen Idec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Treat Oncology Drug Industry Chain Analysis
7.2 Treat Oncology Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Treat Oncology Drug Production Mode & Process
7.4 Treat Oncology Drug Sales and Marketing
7.4.1 Treat Oncology Drug Sales Channels
7.4.2 Treat Oncology Drug Distributors
7.5 Treat Oncology Drug Customers
8 Treat Oncology Drug Market Dynamics
8.1 Treat Oncology Drug Industry Trends
8.2 Treat Oncology Drug Market Drivers
8.3 Treat Oncology Drug Market Challenges
8.4 Treat Oncology Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Treat Oncology Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Treat Oncology Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Treat Oncology Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Treat Oncology Drug Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Treat Oncology Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Treat Oncology Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Treat Oncology Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Treat Oncology Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Treat Oncology Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Treat Oncology Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Treat Oncology Drug, Product Type & Application
Table 12. Global Key Manufacturers of Treat Oncology Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Treat Oncology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treat Oncology Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Treat Oncology Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Treat Oncology Drug Sales by Region (2018-2023) & (Units)
Table 18. Global Treat Oncology Drug Sales Market Share by Region (2018-2023)
Table 19. Global Treat Oncology Drug Sales by Region (2024-2029) & (Units)
Table 20. Global Treat Oncology Drug Sales Market Share by Region (2024-2029)
Table 21. Global Treat Oncology Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Treat Oncology Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Treat Oncology Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Treat Oncology Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Treat Oncology Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Treat Oncology Drug Sales by Country (2018-2023) & (Units)
Table 27. North America Treat Oncology Drug Sales by Country (2024-2029) & (Units)
Table 28. North America Treat Oncology Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Treat Oncology Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Treat Oncology Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Treat Oncology Drug Sales by Country (2018-2023) & (Units)
Table 32. Europe Treat Oncology Drug Sales by Country (2024-2029) & (Units)
Table 33. Europe Treat Oncology Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Treat Oncology Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Treat Oncology Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Treat Oncology Drug Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Treat Oncology Drug Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Treat Oncology Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Treat Oncology Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Treat Oncology Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Treat Oncology Drug Sales by Country (2018-2023) & (Units)
Table 42. Latin America Treat Oncology Drug Sales by Country (2024-2029) & (Units)
Table 43. Latin America Treat Oncology Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Treat Oncology Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Treat Oncology Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Treat Oncology Drug Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Treat Oncology Drug Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Treat Oncology Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Treat Oncology Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Treat Oncology Drug Sales (Units) by Type (2018-2023)
Table 51. Global Treat Oncology Drug Sales (Units) by Type (2024-2029)
Table 52. Global Treat Oncology Drug Sales Market Share by Type (2018-2023)
Table 53. Global Treat Oncology Drug Sales Market Share by Type (2024-2029)
Table 54. Global Treat Oncology Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Treat Oncology Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Treat Oncology Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Treat Oncology Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Treat Oncology Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global Treat Oncology Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Treat Oncology Drug Sales (Units) by Application (2018-2023)
Table 61. Global Treat Oncology Drug Sales (Units) by Application (2024-2029)
Table 62. Global Treat Oncology Drug Sales Market Share by Application (2018-2023)
Table 63. Global Treat Oncology Drug Sales Market Share by Application (2024-2029)
Table 64. Global Treat Oncology Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Treat Oncology Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Treat Oncology Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Treat Oncology Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Treat Oncology Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global Treat Oncology Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Novartis AG Corporation Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Novartis AG Treat Oncology Drug Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. CELGENE CORPORATION Corporation Information
Table 76. CELGENE CORPORATION Description and Business Overview
Table 77. CELGENE CORPORATION Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CELGENE CORPORATION Treat Oncology Drug Product
Table 79. CELGENE CORPORATION Recent Developments/Updates
Table 80. Merck & Company Inc Corporation Information
Table 81. Merck & Company Inc Description and Business Overview
Table 82. Merck & Company Inc Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Merck & Company Inc Treat Oncology Drug Product
Table 84. Merck & Company Inc Recent Developments/Updates
Table 85. Pfizer Inc. Corporation Information
Table 86. Pfizer Inc. Description and Business Overview
Table 87. Pfizer Inc. Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Pfizer Inc. Treat Oncology Drug Product
Table 89. Pfizer Inc. Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Johnson & Johnson Treat Oncology Drug Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Roche Treat Oncology Drug Product
Table 99. Roche Recent Developments/Updates
Table 100. GlaxoSmithKline plc Corporation Information
Table 101. GlaxoSmithKline plc Description and Business Overview
Table 102. GlaxoSmithKline plc Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. GlaxoSmithKline plc Treat Oncology Drug Product
Table 104. GlaxoSmithKline plc Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AstraZeneca Treat Oncology Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Teva Pharmaceutical Industries Ltd Corporation Information
Table 111. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 112. Teva Pharmaceutical Industries Ltd Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Teva Pharmaceutical Industries Ltd Treat Oncology Drug Product
Table 114. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 115. Takeda Corporation Information
Table 116. Takeda Description and Business Overview
Table 117. Takeda Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Takeda Treat Oncology Drug Product
Table 119. Takeda Recent Developments/Updates
Table 120. Astellas Corporation Information
Table 121. Astellas Description and Business Overview
Table 122. Astellas Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Astellas Treat Oncology Drug Product
Table 124. Astellas Recent Developments/Updates
Table 125. NATCO Pharma Limited Corporation Information
Table 126. NATCO Pharma Limited Description and Business Overview
Table 127. NATCO Pharma Limited Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. NATCO Pharma Limited Treat Oncology Drug Product
Table 129. NATCO Pharma Limited Recent Developments/Updates
Table 130. Amgen Corporation Information
Table 131. Amgen Description and Business Overview
Table 132. Amgen Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Amgen Treat Oncology Drug Product
Table 134. Amgen Recent Developments/Updates
Table 135. Ipsen Corporation Information
Table 136. Ipsen Description and Business Overview
Table 137. Ipsen Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Ipsen Treat Oncology Drug Product
Table 139. Ipsen Recent Developments/Updates
Table 140. Aurobindo Pharma Corporation Information
Table 141. Aurobindo Pharma Description and Business Overview
Table 142. Aurobindo Pharma Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Aurobindo Pharma Treat Oncology Drug Product
Table 144. Aurobindo Pharma Recent Developments/Updates
Table 145. Hikma Pharmaceuticals PLC Corporation Information
Table 146. Hikma Pharmaceuticals PLC Description and Business Overview
Table 147. Hikma Pharmaceuticals PLC Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Hikma Pharmaceuticals PLC Treat Oncology Drug Product
Table 149. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 150. Mylan Corporation Information
Table 151. Mylan Description and Business Overview
Table 152. Mylan Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Mylan Treat Oncology Drug Product
Table 154. Mylan Recent Developments/Updates
Table 155. Sanofi Corporation Information
Table 156. Sanofi Description and Business Overview
Table 157. Sanofi Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Sanofi Treat Oncology Drug Product
Table 159. Sanofi Recent Developments/Updates
Table 160. Bayer Corporation Information
Table 161. Bayer Description and Business Overview
Table 162. Bayer Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Bayer Treat Oncology Drug Product
Table 164. Bayer Recent Developments/Updates
Table 165. Biogen Idec Corporation Information
Table 166. Biogen Idec Description and Business Overview
Table 167. Biogen Idec Treat Oncology Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Biogen Idec Treat Oncology Drug Product
Table 169. Biogen Idec Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Treat Oncology Drug Distributors List
Table 173. Treat Oncology Drug Customers List
Table 174. Treat Oncology Drug Market Trends
Table 175. Treat Oncology Drug Market Drivers
Table 176. Treat Oncology Drug Market Challenges
Table 177. Treat Oncology Drug Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Treat Oncology Drug
Figure 2. Global Treat Oncology Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Treat Oncology Drug Market Share by Type in 2022 & 2029
Figure 4. Chemotherapy Drug Product Picture
Figure 5. Targeted Therapy Drug Product Picture
Figure 6. Immunotherapy Drug Product Picture
Figure 7. Hormone Therapy Drug Product Picture
Figure 8. Others Product Picture
Figure 9. Global Treat Oncology Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Treat Oncology Drug Market Share by Application in 2022 & 2029
Figure 11. Blood Cancer
Figure 12. Breast Cancer
Figure 13. Gastrointestinal Cancer
Figure 14. Prostate Cancer
Figure 15. Lung Cancer
Figure 16. Others
Figure 17. Global Treat Oncology Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Treat Oncology Drug Market Size (2018-2029) & (US$ Million)
Figure 19. Global Treat Oncology Drug Sales (2018-2029) & (Units)
Figure 20. Global Treat Oncology Drug Average Price (US$/Unit) & (2018-2029)
Figure 21. Treat Oncology Drug Report Years Considered
Figure 22. Treat Oncology Drug Sales Share by Manufacturers in 2022
Figure 23. Global Treat Oncology Drug Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Treat Oncology Drug Players: Market Share by Revenue in 2022
Figure 25. Treat Oncology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Treat Oncology Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. North America Treat Oncology Drug Sales Market Share by Country (2018-2029)
Figure 28. North America Treat Oncology Drug Revenue Market Share by Country (2018-2029)
Figure 29. United States Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Europe Treat Oncology Drug Sales Market Share by Country (2018-2029)
Figure 32. Europe Treat Oncology Drug Revenue Market Share by Country (2018-2029)
Figure 33. Germany Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Treat Oncology Drug Sales Market Share by Region (2018-2029)
Figure 39. Asia Pacific Treat Oncology Drug Revenue Market Share by Region (2018-2029)
Figure 40. China Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Treat Oncology Drug Sales Market Share by Country (2018-2029)
Figure 50. Latin America Treat Oncology Drug Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Treat Oncology Drug Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Treat Oncology Drug Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Treat Oncology Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of Treat Oncology Drug by Type (2018-2029)
Figure 60. Global Revenue Market Share of Treat Oncology Drug by Type (2018-2029)
Figure 61. Global Treat Oncology Drug Price (US$/Unit) by Type (2018-2029)
Figure 62. Global Sales Market Share of Treat Oncology Drug by Application (2018-2029)
Figure 63. Global Revenue Market Share of Treat Oncology Drug by Application (2018-2029)
Figure 64. Global Treat Oncology Drug Price (US$/Unit) by Application (2018-2029)
Figure 65. Treat Oncology Drug Value Chain
Figure 66. Treat Oncology Drug Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 高カリウム血症治療薬の世界市場2023年：パティロマー、シクロケイ酸ジルコニウムナトリウム
  • カルシトリオール医薬品の世界市場2023年：注射剤、錠剤
  • 第IX因子複合薬の世界市場2023年：ベリプレックス、プロフィルニン、オクタプレックス、プロトロンプレックス、コファクト、その他
  • 医薬品消毒/滅菌装置の世界市場2023年：加熱殺菌、薬品殺菌、フィルター殺菌、電離放射線殺菌
  • 薬剤被覆バルーン拡張カテーテルの世界市場2023年：バルーン径 3-12mm、バルーン径 12mm以上
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8911 )"がん治療薬の世界市場2023年：化学療法薬品、分子標的治療薬品、免疫療法薬品、ホルモン療法薬品、その他" (英文：Global Treat Oncology Drug Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。